<!DOCTYPE html>
<html>
<head>
	<title>DRUG POLICY</title>
	<style type="text/css">

				h1,h3{color: darkgreen;

				}
		.superback{
				padding:9px;
				background-color: green;
				height: 13000px; 
				display: flex; 
				}

		.back{
				background-color: green;
				height: 13000px;
				flex: 1;  
				}

		.content{
			    padding:60px;
				background-color: white;
				height: 13000px;
				flex: 80;  
				}

		/*.content2{
				background-color: white;
				height: 1000px;
				flex: 10;  
				}*/
	</style>
	
</head>
<body>
	<div class="superback">
		<div class="back"></div>	
		<div class="content">
			<div class=WordSection1>

<center><h1>FEDERAL MEDICAL CENTRE, KEFFI</h1><br>
						

						<h2>DRUG POLICY<br></h2>
			 							

			 						<br><br><br><br>

			 						 DRAFT			
</center>
										<br><br><br><br>



<div class=WordSection1>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>1.0
INTRODUCTION<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Sustained
availability, affordability, appropriate pricing and rational use of
drugs/medicines has remained a major challenge in public health institutions in
Nigeria. This challenge the Federal Centre, Keffi has decided to tackle with setting
up of drug and therapeutics committee and the formulation of its hospital drug
policy which is a modification / an adaptation of the national drug policy.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Drug
policies provide policy framework and guidelines towards sustainable financing
of drug, procurements, continuous availability of safe and effective drugs and
their rational use.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Formulation
of the policy presents an excellent opportunity for the development of new
strategies for consolidating achievements in areas where progress has been recorded
and address those areas that call for some positive actions.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>It
is hoped that with judicious implementation of the policy, the patients will
have sustainable access to safe, effective good quality drugs and their
rational use.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>2.0 DEFINITION<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Drugs
include any substance or mixture of substances manufactured , sold or
advertised for use in the diagnosis , treatment, mitigation or prevention of
any disease, disorder, abnormal physical state , or the symptoms thereof, in
man or in animals, restoring, correcting or modifying organic functions in man
or animals, disinfection, or the control of venoms, insects or pests or
contraceptives.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>3.0 GOALS OF THE HOSPITAL DRUG POLICY<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
goals of the policy shall be to make available at all times to the patients adequate
supplies of drugs that are effective, affordable, safe and of good quality to
ensure the rational use of that drugs and also to ensure sustainable financing
and reasonable profitability.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>4.0 OBJECTIVES OF THE HOSPITAL DRUG POLICY<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objectives of drug policy are:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
To ensure efficient drug management in the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
To ensure access to safe, effective, affordable and good quality drugs at all
times.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
To promote the rational use of drugs by prescribers, dispensers and consumers<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
To promote local compounding of formulations and other profit generating
ventures<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
To ensure that all drugs in the hospital’s drug distribution system are safe,
efficacious, effective and of good quality<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
To promote drug utilization research and drug utilization review (based on the
research findings)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VII.
To strengthens administrative. Legislative and regulatory control of
procurement, storage, distribution, prescription and use of drugs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VIII.
To enlist hospital management commitment towards the achievement of the goals
and objectives of the Hospital Drug Policy<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.0 STRATEGIES FOR IMPLEMENTING THE HOSPITAL DRUG
POLICY<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
strategies to be used to implement the hospital drug policy shall focus on
effective drug management process such as rational drug selection, proper
quantification of drugs needs and effective procurement practices. Others shall
include assurance of quality of drugs at all times, appropriate storage, proper
costing and effective distribution, monitoring and evaluation. Furthermore, the
strategies shall emphasize proper accountability, external controls and
rational use of drugs by health workers and consumers<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.1SELECTION OF DRUGS<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objectives of the drugs selection process are to have a list of drugs
rationally chosen to satisfy the health care needs of the majority of the
population.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Such
a list shall be released regularly and shall form the basis of drug
procurement, prescription and dispensing.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
list shall constitute the hospital’s drug formulary and shall include, majorly,
drugs on the essential drug list and the standard treatment guidelines
published by the Federal Ministry of Health. In this regards, the Hospital
shall take the following steps:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
A Hospital formulary shall be produced and made available to prescribers,
dispensers and service outlets within the Hospital. The formulary shall be managed
by the formulary subcommittee of the hospitals drug therapeutic committee<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Drugs included in the formulary shall<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
be listed using generic or international non-proprietary names (INN)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
be based on the health needs of the majority of the population<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
have substantial safety and risk/benefits ratio with sufficient accumulated
scientific data<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
As much as possible, formulations containing more than one active ingredients
shall be avoided, unless one or more of the following criteria are met:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
The clinical condition justifies the use of more than one drug in a fixed
combinations<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Two or more pharmacologically active ingredients are synergically active in a
product, or<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Patient compliance is enhanced by the combination<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iv.
When two or more drugs are therapeutically equivalent or several drugs are
available for the same indication, preference shall be given to products with<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Most scientist research and clinical data<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Most favorable pharmacokinetic properties<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Best cost advantage<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Best patient compliance<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Most stable pharmaceutical dosage form for which appropriate storage facilities
exist<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>v.
The hospital formulary shall be updated every two years<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vi.
Suggestions for amendment of the formulary shall be made in writing to the drug
therapeutic committee, justifying each suggested amendments, new drugs shall
only be added to the list of sufficient scientist and clinical data are
available to that they offer distinct advantages over existing ones. Drugs on
the list for which information becomes available that they no longer have favorable
risk/benefit ratio shall be withdrawn and replaced with safer alternatives.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vii.
The hospital formulary shall be used<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
For prescribing drugs<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
The procurement of drugs and their use<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Prescribing drugs<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Drug information to health care providers<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>viii.
The formulary list shall accommodate all drug on the NHIS list and list for the
emergency tray<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.2 PROCUREMENT OF DRUGS<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
procurement process is a major determinant of the safety, quality, efficacy,
affordability and availability of drugs, its objective is to provide drugs on
the basis of relevant information, need and available resources. To address the
situation, the following criteria shall be adhered to<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
the hospital shall be committed to Good Pharmaceutical Procurement Practices (see
annex 1)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Procurement of drugs shall be restricted to drugs registered in Nigeria and on
the National essential drug list and /or the Hospital formulary. Procurement for
NHIS will be restricted to the approved NHIS drugs list.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Procurement shall be by the international non-proprietary Names (INN) or
generic Names only. Brand or company /suppliers preference to be determined by
price /cost, pharmaceutical and pharmacokinetic/bioavailability consideration<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Procurement shall be by open, competitive tender or restricted tender to
prequalified suppliers and shall be conducted in a transparent manner with the
advice of the Pharmacy Department. Emergency procurement can sometimes be
allowed but this shall not be more once within a three month period.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
All procurement processes (both emergency and regular) shall be regularly
audited by the DTC<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
Procurement shall be based on accurate quantification of drug requirement by
the pharmacy department.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VII.
Suppliers that offer discount pricing to the public sector shall be
preferentially/specially considered<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VIII.
Procurement and receipt procedures shall ensure that drugs supplied are of good
quality. Procurement from the open market shall be completely discouraged.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IX.
Receipt procedure shall also be transparent and involve the hospital general
stores and audit department<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>X.
In order to keep prices low and undertake adequate quality assessment, drugs
shall as much as possible be purchased in bulk. A system of yearly orders(based
on quantification) and quarterly delivery shall be encouraged i.e. annual order
but quarterly delivery<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>XI.
Drugs procured at all levels shall be subjected to quality assessment before
distribution to dispensing units.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
procurement process shall aim to<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Procure the right drugs in the right quantities<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Obtain the lowest possible purchase price<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Ensure that all drugs procured meet recognised standards of quality<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Arrange timely to avoid shortages and stock-out<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Ensure supplier reliability with respect to service and quality<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Set the purchasing schedule, formulas for order quantities and safety stock
levels to achieve the lowest total cost at each level of the system<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Achieve these objectives in the most efficient manner possible<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>For
the Hospital, the procurement cycle shall involve the following:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Review of drug selections (based on consumption information)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Determination of the quantities needed<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Reconciliation of needs and funds<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Choosing the procurement method<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Location and selection of suppliers<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Specification of contract terms<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Monitoring of order status<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Receipt and checking of Drugs<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Effecting payment<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Storage and distribution of drugs<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Collection of consumption information.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.3 Drug Resolving Fund Scheme (DRF)<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
DRF scheme is a very effective strategy for ensuring uninterrupted drug supply
in the health care delivery system. It can raise substantial revenue; improve
drug availability and quality of care if appropriately and effectively managed.
The major objective of the scheme shall be to maximise access and encourage
utilization of services and facilities at the Federal Medical Centre, Keffi.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
revolving Fund Scheme, shall be strengthened through<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
The reorganization of the DRF committee for an effective and transparent fund
management<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
Provision of adequate capital for the procurement of drugs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Start-up
financing shall include a “seed-fund” or fund in the DRF account plus the stock
value (based on unit cost of drugs) in the pharmacy minus the drug related debt
profile.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
Maintenance of a separate account for the DRF Scheme which shall be used
exclusively for drug procurement. Proceeds from all drug sales shall be paid
into this account<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iv.
The cost-recovery objective of the DRF shall be full recovery of all drug costs
(based on replacement cost of drugs) and local operating cost.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>v.
DRF committee to manage the account and recommend approval of all payments from
the account<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vi.
Empowering the head of Pharmacy department of the hospital as the custodian of
drugs to the institution and the Project Manager to be one of the signatories
to the DRF account<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vii.
The membership of the DFR committee to include the head of the Pharmacy
department, chairman of the DTC Committee, a senior account, a staff of
internal audit and a senior administrative officer who is also expected to be a
member of the procurement committee for the hospital. The Head of Clinical
Service is expected to head the DFR committee<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>viii.
Credit facilities shall only be extended to establishments and individuals that
have established credit relationships with the Hospital. Drug related credits
are to be monitored closely and reimbursements effected through the hospital
accounts department.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ix.
For NHIS drug related credits, complete reimbursement of balance of payment
into the DFR account is to be ensured<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>x.
Drug related expenses for indigent patients and exemption to be handled by the
hospital management (i.e. full reimbursement into the DFR account)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.4 Finance and Pricing Policy<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Experience
in recent years has shown that drugs are been procured at much higher prices in
public institutions than in private retail Pharmacies. Therefore, to ensure
affordability of drugs in the hospital, management shall establish necessary
mechanism to guarantee that drug supply to patients shall cost less than in the
private sector.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>To
achieve the above objective:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
The procurement processes shall ensure that drugs are obtained at lowest
possible cost without compromising quality, safety and efficacy<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Consideration shall be specifically given to supplier with discount policy for
public health institutions.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
A policy of differential mark up (range 10-30%) shall be adopted. factors to be
considered includes whether the drug is considered vital, essential or Non-essential
and the expenditure involved in their procurement.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Cost to be built into unit cost of drugs for sale to patient include drug cost
(replacement cost and local operating cost) and mark up. Cost component allocation
shall be objective, transparent and subject to periodic review.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
Cost allocation for every drug shall be based on replacement cost, operating
cost and mark up. This allocation shall be objective, transparent and subject
to periodic review and approval by the DTC<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
A monthly stock taking exercise shall be undertaken to ascertain stock level
and declare profit or loss. Periodic Spot checks is also encouraged.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><b
style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.5 Drug Storage and Inventory Management<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objectives of drug storage shall be to ensure stock security and maintenance of
the quality of drugs throughout their shelf life.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Inventory
management shall ensure adequate stock (safely, pipeline and in-use) at all
times and as much as possible prevent stock outs and expiration of drugs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
The hospital shall ensure that the main Pharmacy store is suitably located, of
adequate size, well equipped and secured<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
The Pharmacist who shall be charged shall have adequate training in logistic
and inventory management.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
The ward/ emergency tray stocks shall be managed by pharmacist from the
inpatient unit of the Pharmacy.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>In
addition, the following measures shall be implemented<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
A main storage site shall exist in the hospital. This shall ensure that drugs
do not expire or deteriorated in the shelf. However, any stock of expired or
deteriorated drugs shall be officially destroyed within six months<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Regular checks on the quality of stored drugs shall undertake to ensure that
they do not deteriorate under storage conditions<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Adequate mechanism shall be put in place to ensure that the temperature in all
drug storage facilities is maintained at not more than 200c for the entire
shelf life of the drugs. Appropriate cold storage shall be provided for the
maintenance of the shelf life of vaccines and biological products.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Management shall ensure the establishment of computerized inventory control
systems for effective drug management<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
The Pharmacy Department, along with the department of Finance (Account and
Internal Audit) shall carry out an end of year stock taking exercise. This
shall be part of a comprehensive audit process of stocks, ledgers, sales,
account etc<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
Adequate security shall be provided for the storage areas<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><b
style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.6 Drug Distribution.<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Rational
drug distribution channels shall be promoted in this hospital.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>In
this regards, the following measures shall be enforced by the hospital
management<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Drug distribution, inventory control in outlets, sale and dispensing shall be
under the control and supervision of Pharmacists<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Drugs shall be distributed to dispensing outlets on a rational basis:
considerations shall include storage facilities at the outlets ,type of patient
and proximity to points of use<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Dispensing outlets shall include<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(a)
Outpatient outlet<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Shall operate form 800am-400pm on week days<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Handle outpatients especially GOPD and specialist clinic patients<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(b)
Inpatient dispensing outlets<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Mainly for inpatients<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
To be operational for 24 hours<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(c)
Accident and Emergency dispensing outlet<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Shall be operational for 24 hours<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Handles patient in the casualty and others (during call periods)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(d)
Other outlets (Obstetrics and Gynecology, Pediatrics, Theatre, Intensive Care
Unit)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>-
Operational for 24 hours<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Emergency Tray (ET)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Emergency trays to be set up in all the wards, lying and delivery room and
Intensive care unit<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
List of drug on the ET to be produced by the DTC as part of the formulary<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Drug stock on the ET is to be managed by the pharmacist in conjunction with the
Nursing Staff in charge of the units<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>&#8722;
Efforts shall be made to prevent stock out, deterioration in quality and
expiration of drugs on the ET and all the dispensing outlets<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
For patients, individuals drug order or in some cases, unit dose distribution
system as opposed to the bulk ward replenishment. This is to reduce risk of
deterioration in quality and scattered stock and losses<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7 Rational Drug Use (RDU)<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
requirements for rational drug use are that the right drugs shall be used for
the right indications in the right dose and dosage form for the right duration.
RDU seeks to avoid the all-too-frequent problems of under-and
over-prescription, inappropriate prescription (especially of antibiotics and
injections) and the use of new, expensive, well expensive drugs when equally
effective, well-tried, safe and cheaper alternative are available. Concerted
efforts shall be made to promote rational drug use through:<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.1 Educational and Training<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objective is to ensure that all health personnel involved in the diagnosis,
prescription and dispensing of drugs, as well as consumers, receive adequate
theoretical and practical training in rational drug use. The following would be
necessary:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
Periodic seminar on promoting rational Drug use-in conjunction with Food and
Drugs division of FMOH, NAFDAC and WHO Country Office<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
Monthly Hospital Drug use and Therapeutic seminar<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
The continuing medical Education Committee and clinical departments in the
hospital to be encouraged to come up and sustain education and training
materials.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iv.
Stakeholder involved in drug use to be encouraged to go for appropriate
trainings to enhance their efficiency<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.2 Rational Prescribing<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objective is to ensure that drugs are prescribed rationally. Consequently,<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
Up-to- date standard Treatment Guideline and the Hospital Formulary shall be
made available to all prescribers in the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
Prescribing shall be by International Non-proprietary Names (INN) or generic
names.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
Only duly qualified and licensed medical practitioners shall have authority to
prescribe drugs. each prescriber in the hospital shall have an assigned code
which along with the prescriber’s name and sample signature shall with the
pharmacy and the office if the head of clinical services<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iv.
Prescriptions sheets. For outpatients, the sheet shall be in triplicate (a copy
each for the pharmacy, accounts and records with DTC/HCS) and for inpatients ,
the inpatients treatment /prescription sheet which shall be kept with the bed
head ticket and the patients case note<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>v.
Minimum items on the prescription sheet to include patients and prescriber
details. Generic name of drugs, formulation, route of administration strength,
dose and duration of use, prescribers name to include full names code number
and signature<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vi.
Discharge (for inpatients) To-Take-Home(TTH) drugs should be prescribed and
dispensed as inpatient, then handed over to the patient/relations, with
appropriate drug information, before patient leaves for home<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vii.
Effort shall be made to provide appropriate drug information at prescription
point<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>viii.
Feedback on effect (both benefit and adverse) of drug shall be encouraged<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ix.
Electronic Prescription System shall be adopted and Perfected in all units of
the Hospital. When perfected, this shall replace items iv – vi above.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.3 Rational Dispensing<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
objective of rational dispensing shall be to ensure that an effective form of
the correct drug is delivered to the right patient, in the prescribed dosage
and quantity with clear instruction and in a package that maintains the potency
of the drug. In this regard:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
Dispensing shall only be carried out within the identified outlets<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
The minimum information requirement on the label of a dispensed medicine shall
be the following: Name of patient, Generic Name of dispensed drug, strength of the
drug, dosage instruction in symbols or words as may be appropriate, duration of
treatment, date of dispensing and the name of the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
The patient shall be counselled on the use of dispensed drugs, in conducive
environment suitable for effective communication<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iv.
Dispensing shall be carried out in a sustainable container that will be
child-proof and ensure the stability of the drug dispensed<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>v.
Generic substitution: different brands of the same drug when brand name is used
for prescription can be substituted. Substitution of different drugs within the
same class shall not be encouraged. Suggestions can however be made to the
prescriber about reviewing his prescriptions<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vi.
For inpatients : a pharmacist desk shall be set up in each ward to collate
inpatient prescription forward for collection, review collected drugs and
handle the distribution of the drugs to the patients drug cupboards. Designated
Clinician assistants/pharmacy technician shall be involved in drug collection
for inpatients.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>vii.
Adequate record of dispensed drugs shall be encourage<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>viii.
The dispensing process shall include the following:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>a)
Receipt and validation of prescription<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>b)
Understanding and interpretation of the prescription<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>c)
Preparation of items for issue<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>d)
Recording of the action taken<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>e)
Issuance of medicine to patient/ clinical assistant/ pharmacist technician with
clear instruction and advice<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.4 Medication Administration<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Inpatients
are usually more sick (compared to outpatients) require more medications (most
to be administered parentally) and are more prone adverse effects. Appropriate
and complete medication administration is therefore very essential. The
objective of medication administration shall be to ensure complete compliance,
avoidance of medication error, appropriate review of inpatient prescription and
monitoring the effect (both beneficial and harmful) of prescription
medications.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>To
ensure the above:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Medication administration shall generally be the responsibility of the nursing
staff. In some cases, clinicians may administer drugs as intravenous,
intrathecal, anesthetic drugs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Medications administered shall be chartered /recorded appropriately on
prescribed medication Administration Recording (MAR) sheet<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
The MAR sheet shall among other things contain details of prescriber,
medication, prescribed write, dosage and duration, timing of administration and
the detail (Name and Signature) of the person and time of medicine
administration<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Monitoring the effect of the drugs on the patient and ordering appropriate
changes in the therapy shall primarily be the responsibility of the clinician.
However, Observation and reporting shall be required for the person
administering the medication. The input of a clinical pharmacist shall be
considered important<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
Inpatients prescription shall not be for more than 72hours (3-days) at the
first instance then subsequently 5-days interval. This is to allow for review
of medications and avoid continuous unintended administration of medicines.
This policy shall not apply to medicines with defined duration of therapy (e.g.
antituberculous and antiretroviral drugs)<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.5 Drug and therapeutic Committee<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Drugs
and therapeutic committees are institutional mechanism for promoting,
implementing and monitoring the concept of rational drug use in health care
institutions. Therefore the following measures shall be taken:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
The drug and therapeutics committee (DTC) shall be established as an
institutional standing committee of the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
Membership of the committee shall comprise of representatives of the
pharmaceutical, nursing, medical and administrative services of the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
The DTC shall, among other duties be responsible for:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
The selection of drugs for use in the institution, based on the National
Essential Drug list<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
The accurate of estimation of pharmaceutical requirements for the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Monitoring the use of therapeutic guidelines and over all drug utilization, and<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>•
Monitoring of the rational use drugs in the hospital.<o:p></o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.7.6 Drug Information Services<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Drug
information is intended to provide unbiased, scientifically validated drug
information to promote rational prescribing, dispensing and use. In this
respect, therefore, the following measures shall be taken:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
A drug information unit shall be established in the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
The drug information unit shall , at all times, be suitably equipped and
provided with up-to-date reference materials and equipment, including computer
hard and soft wares and internet access, to guarantee the acquisition and
dissemination of current and accurate drug information<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
The drug information shall be manned by pharmacist who shall be available at
the desk during working period. Provision shall be made for drug information
services to be provided during call periods<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
A register shall be kept of all requests (both written and oral, by phone) and
the response given. This shall be audited, reviewed and updated periodically.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.8 Pharmacovigilance<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Since
no active drug is entirely free from adverse reactions, an adverse drug
reaction reporting system shall be seen as an essential component of the health
care delivery system<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
A Pharmacovigilance unit/center shall be established to collect, evaluate and
disseminate relevant information on adverse drug reactions (ADR) and poisoning.
This center shall co-exist with the drug information unit as the drug
information and pharmacovigilance center.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
All drugs used in the hospital shall be regularly monitored with respect to
their efficacy, safety, quality as well as adverse reactions of their use and
their inclusion in the hospital formulary<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
The unit shall relate closely with the pharmacovigilance unit of NAFDAC to
ensure that all ADR Alert are appropriately and promptly communicated to the
prescribers and dispensers and also to ensure that drugs to be withdrawn are
promptly delisted from the formulary<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
An institutional focal person on pharmacovigilance shall be appointed by the
DTC, who shall co-ordinate all matters related to pharmacovigilance (including
the pharmacovigilance committee)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
A system of spontaneous reporting using the prescribed form shall be
encouraged. Special cohorts can be periodically studies to determine prevalence
of ADRs. ADR desk shall also exist in the GOPD, Specialist Clinics, dispensing
outlets and the wards for people to lodge ADR related complaints<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
The hospital shall keep its own registry of ADR, which shall also be considered
in the management of the hospital formulary.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VII.
Reported forms, Reports of cohort studies and details in ADR registry shall be
forwarded to NAFDAC to update their profile and casualty evaluations.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.9 Drug Promotion<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Information
about drugs is usually provided by manufacturers who are often out to promote
their brands. Since the HDP does not promote brands, the activity of marketing
details manufacturers and suppliers shall be regulated.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>To
this end-<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Drug Promotional activities shall be regulated by the DTC<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
No marketing detail shall organize Drug promotional activities without the
knowledge and approval of the DTC.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Promotional activities that could be seen as biasing the prescriber shall be
discouraged<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Pasting of promotional posters in prescribing outlets by detailers of
manufacturers/Suppliers shall be discouraged<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
Promotional activities should emphasise the generic names of the product. Brand
Names should only be as a means of relating a product to a particular
Manufacturer/ Supplier.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
The process of selection of the brand of a particular product to stock shall be
transparent and based only on scientific and cost effectiveness considerations.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.10 Control Measure<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>To
promote accountability and transparency, minimize loss and enhance
profitability, control measures shall be put in place, monitored and enforced.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>a)
Procurement and Sales<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Drug procurement shall be handled by the hospital central procurement committee
in conjunction with the revolving fund committee and the pharmacy Department.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
List and quantity of drugs to be procured shall be approved by the DTC before
forwarding to the DRF and the procurement committee<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Suppliers shall be prequalified and registered with the hospital. The tender
process shall be transparent and follow due process<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Emergency procurement of drugs shall be discouraged / minimized only when
presented as being absolutely necessary by the DTC<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
Receipt of procured drugs in conjunction with the security, stores, account and
internal audit departments<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VI.
There shall be daily reconciliation of sales (pharmacy and accounts copy of
receipt s, record of dispensed drugs and actual cash lodgement.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>VII.
There hall an end of the year summary of sales, stock balance and declaration
of profit or loss<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>b)
Stores and inventory Management<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Security department shall ensure adequate watch over items in the pharmacy
department to avoid loss<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
The pharmacy shall ensure strict inventory control and management to avoid
deterioration and expiration of drugs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Periodic checks by the internal Audit department on actual stocks, bin cards,
ledgers and documentation of drug movement and dispensing<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>c)
Drug Utilization- these measure shall be in place<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
Restricting access and customized prescription sheets with prescriber’s
identification.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>ii.
Periodic review of prescription and dispensing records<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>iii.
Annual Drug Utilization Review- to examine prescription and dispensing
patterns, medication error and drug consumption patterns.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.11 Research and Human Resources Development<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>a)
Research shall be encouraged in the following areas<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Drug utilization and promoting rational drug use<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Pharmacovigilance and safety<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Pharmaco economics and cost effectiveness analysis<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IV.
Social cultural aspects drug use<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>V.
Other areas of interest to the hospital<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>b.
Well trained and experienced professional, managerial, technical and other
personnel are essential for planning, organizing and implementing this policy.
Management shall therefore<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>I.
Strengthen the capacity of stakeholders in the drug use cycle<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>II.
Develop in-service training programme to address on-the-job requirements in the
implementation of the policy<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:72.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>III.
Promote co-operation with relevant Government international Agencies (e.g.
FMOH, NAFDAC, WHO) and Research Institute for the purpose of implementing these
policies.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:
"Times New Roman","serif"'>5.12 Monitoring and Evaluation<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>The
success of this policy would depend on how well its provisions are implemented.
Mechanism shall, therefore, be put in place for monitoring, measuring and
evaluating the policy’s performance and impact, and for identifying possible
problems and evolving effective strategies to address them. In this Regard<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>i.
The policy subcommittee of the DTC shall serve as a monitoring unit, to measure
progress in the implementation of the policy<o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><span
lang=EN-US style='font-size:12.0pt;line-height:115%;